21/10/2025
‼️永立榮生醫UA002 Bio Japan展前亮相 驚艷國際 ‼️
--------------------------------------------------
U-Neuron Biomedical Inc. made its appearance during the Link-J investment promotion session ahead of the Bio Japan exhibition on October 7, introducing its new amniotic fluid stem cell-based drug UA002. Bio Japan is Asia's leading medical exhibition focusing on regenerative medicine. The Global Life Science Session organized by Link-J gathered participants from over ten countries, including the United States, Japan, Europe, Asia, and Australia. Led by the Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) of Ministry of Economic Affairs, the delegation showcased Taiwan's outstanding biomedical companies during the international investment session.
Judy Juang (COO) presented the company's new drug UA002 for treating erectile dysfunction, which shows strong potential for nerve regeneration. Clinical results demonstrated excellent efficacy in patients unresponsive to oral medications. Multiple research papers on UA002 have already been published in prestigious international journals. This participation successfully captured international attention in Japan, one of the world's leading countries in regenerative medicine.
再生醫療公司永立榮生醫，在10月7日Bio Japan展會前的Link-J招商時段亮相，介紹旗下羊水幹細胞新藥UA002。Bio Japan是亞洲指標級醫療展，是再生醫療的最佳舞台。Link-J 的Global Life Science Session 匯集了美、日、歐、亞、澳等超過10個國家與會，本次由經濟部生醫小組（BPIPO）率團，安排於上述Link-J的國際招商時段，介紹台灣績優生醫公司。
永立榮營運長莊欣怡介紹旗下性功能障礙新藥UA002，具促進神經再生潛力，臨床針對口服藥物無效之勃起功能障礙顯示效果卓越，多篇研究論文已登上國際權威期刊。此次更於再生醫療先驅日本，吸引國際目光。
